1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
3
|
Wang H, Zhang H, Deng P, Liu C, Li D, Jie
H, Zhang H, Zhou Z and Zhao YL: Tissue metabolic profiling of human
gastric cancer assessed by 1H NMR. BMC Cancer. 16:3712016.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Jung J, Jung Y, Bang EJ, Cho SI, Jang YJ,
Kwak JM, Ryu DH, Park S and Hwang GS: Noninvasive diagnosis and
evaluation of curative surgery for gastric cancer using NMR-based
metabolomic profiling. Ann Surg Oncol. 21 Suppl 4:S736–S742. 2014.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Zhao X, Wang Y, Deng R, Zhang H, Dou J,
Yuan H, Hou G, Du Y, Chen Q and Yu J: miR186 suppresses prostate
cancer progression by targeting Twist1. Oncotarget. 7:33136–33151.
2016.PubMed/NCBI
|
6
|
Farazi TA, Hoell JI, Morozov P and Tuschl
T: MicroRNAs in human cancer. Adv Exp Med Biol. 774:1–20. 2013.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Shen ZL, Wang B, Jiang KW, Ye CX, Cheng C,
Yan YC, Zhang JZ, Yang Y, Gao ZD, Ye YJ, et al: Downregulation of
miR-199b is associated with distant metastasis in colorectal cancer
via activation of SIRT1 and inhibition of CREB/KISS1 signaling.
Oncotarget. 7:35092–35105. 2016.PubMed/NCBI
|
8
|
MacLean JA II, King ML, Okuda H and
Hayashi K: WNT7A regulation by miR-15b in ovarian cancer. PLoS One.
11:e01561092016. View Article : Google Scholar : PubMed/NCBI
|
9
|
Li J, Chen Y, Guo X, Zhou L, Jia Z, Tang
Y, Lin L, Liu W and Ren C: Inhibition of miR-15b decreases cell
migration and metastasis in colorectal cancer. Tumour Biol.
37:8765–8773. 2016. View Article : Google Scholar : PubMed/NCBI
|
10
|
Zhang Y, Huang F, Wang J, Peng L and Luo
H: MiR-15b mediates liver cancer cells proliferation through
targeting BCL-2. Int J Clin Exp Pathol. 8:15677–15683.
2015.PubMed/NCBI
|
11
|
Sun G, Yan S, Shi L, Wan Z, Jiang N, Li M
and Guo J: Decreased expression of miR-15b in human gliomas is
associated with poor prognosis. Cancer Biother Radiopharm.
30:169–173. 2015. View Article : Google Scholar : PubMed/NCBI
|
12
|
Zhang WL, Zhang JH, Wu XZ, Yan T and Lv W:
miR-15b promotes epithelial-mesenchymal transition by inhibiting
SMURF2 in pancreatic cancer. Int J Oncol. 47:1043–1053.
2015.PubMed/NCBI
|
13
|
Zhou RP, Chen G, Shen ZL and Pan LQ:
Cinobufacin suppresses cell proliferation via miR-494 in BGC-823
gastric cancer cells. Asian Pac J Cancer Prev. 15:1241–1245. 2014.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
15
|
Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun
S, Hong L, Liu J and Fan D: miR-15b and miR-16 modulate multidrug
resistance by targeting BCL2 in human gastric cancer cells. Int J
Cancer. 123:372–379. 2008. View Article : Google Scholar : PubMed/NCBI
|
16
|
Sun H, Meng X, Han J, Zhang Z, Wang B, Bai
X and Zhang X: Anti-cancer activity of DHA on gastric cancer - an
in vitro and in vivo study. Tumour Biol. 34:3791–3800. 2013.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
18
|
Jiang X, Du L, Wang L, Li J, Liu Y, Zheng
G, Qu A, Zhang X, Pan H, Yang Y, et al: Serum microRNA expression
signatures identified from genome-wide microRNA profiling serve as
novel noninvasive biomarkers for diagnosis and recurrence of
bladder cancer. Int J Cancer. 136:854–862. 2015. View Article : Google Scholar : PubMed/NCBI
|
19
|
Chen Y, Chen J, Liu Y, Li S and Huang P:
Plasma miR-15b-5p, miR-338-5p, and miR-764 as biomarkers for
hepatocellular carcinoma. Med Sci Monit. 21:1864–1871. 2015.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Dai J, Qian C, Su M, Chen M and Chen J:
Gastrokine-2 suppresses epithelial mesenchymal transition through
PI3K/AKT/GSK3beta signaling in gastric cancer. Tumour Biol.
37:12403–12410. 2016. View Article : Google Scholar : PubMed/NCBI
|
21
|
Zhang Y, Du J, Zheng J, Liu J, Xu R, Shen
T, Zhu Y, Chang J, Wang H, Zhang Z, et al: EGF-reduced Wnt5a
transcription induces epithelial-mesenchymal transition via
Arf6-ERK signaling in gastric cancer cells. Oncotarget.
6:7244–7261. 2015. View Article : Google Scholar : PubMed/NCBI
|
22
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Yu X, Li Z, Chan MT and Wu WK: PAQR3: A
novel tumor suppressor gene. Am J Cancer Res. 5:2562–2568.
2015.PubMed/NCBI
|
24
|
Ling ZQ, Guo W, Lu XX, Zhu X, Hong LL,
Wang Z, Wang Z and Chen Y: A Golgi-specific protein PAQR3 is
closely associated with the progression, metastasis and prognosis
of human gastric cancers. Ann Oncol. 25:1363–1372. 2014. View Article : Google Scholar : PubMed/NCBI
|
25
|
Li Z, Ling ZQ, Guo W, Lu XX, Pan Y, Wang Z
and Chen Y: PAQR3 expression is downregulated in human breast
cancers and correlated with HER2 expression. Oncotarget.
6:12357–12368. 2015. View Article : Google Scholar : PubMed/NCBI
|
26
|
Huang W, Guo W, You X, Pan Y, Dong Z, Jia
G, Yang C and Chen Y: PAQR3 suppresses the proliferation, migration
and tumorigenicity of human prostate cancer cells. Oncotarget. Jun
3–2016.(Epub ahead of print). doi: 10.18632/oncotarget.9807.
|
27
|
Guo W, You X, Xu D, Zhang Y, Wang Z, Man
K, Wang Z and Chen Y: PAQR3 enhances Twist1 degradation to suppress
epithelial-mesenchymal transition and metastasis of gastric cancer
cells. Carcinogenesis. 37:397–407. 2016. View Article : Google Scholar : PubMed/NCBI
|